programma definitivo - SocietÃ italiana di neurologia

More documents

Recommendations

Info

4 N O V E M B R E • A R E A P O S T E R 496. FIVE-YEAR EDSS DISABILITY AFTER THE FIRST DEMYELINATING EPISODE (CLINICALLY ISOLATED SYNDROME): THE GERONIMUS PROSPECTIVE COHORT R. D’ALESSANDRO, E. BALDIN, M. BENEDETTI, M. GALEOTTI, F. GRANELLA, M. LEONE, A. LUGARESI, S. MALAGU’, E. MONTANARI, L. MOTTI, W. NERI, M. SANTANGELO, C. SCANDELLARI, M. TOLA, L. VIGNATELLI, - ON BEHALF OF THE GERONIMUS STUDY GROUP (Bologna, New York - USA, Verona, Lugo di Romagna - RA, Parma, Novara, Chieti, Cesena, Fidenza - PR, Reggio Emilia, Forlì - FC, Carpi - MO, Ferrara) 497. THE “FRAILTY” OF MULTIPLE SCLEROSIS AND ITS EFFECT ON SOCIAL AND HEALTHCARE COST BURDEN: THE EXPERIENCE OF FERRARA, ITALY E. BALDI, V. TOZZI, G. PACILEO, N. NAPOLI, L. CANIATTI, S. BIANCHI, G. ROVERSI, R. TOLA (Ferrara, Milano) 498. TAPENTADOL FOR TREATING PAIN IN MULTIPLE SCLEROSIS PATIENTS C. SOLARO, E. TRABUCCO, M. CELLA, P. TANGANELLI (Genova) 499. UPPER LIMB FUNCTION AFTER FAMPRIDINE TREATMENT: AN OPEN MULTICENTER LABEL STUDY C. SOLARO, E. TRABUCCO, D. CATTANEO, M. CELLA, P. TANGANELLI, M. ROVARIS (Genova, Milano) 500. TRANSCRANIAL DIRECT CURRENT STIMULATION OF MOTOR CORTEX DOES NOT AMELIORATES SPASTICITY IN MULTIPLE SCLEROSIS R. IODICE, F. MANGANELLI, L. RUGGIERO, R. DUBBIOSO, S. MONTELLA, P. CARRIERI, L. SANTORO (Napoli) 501. ROLE OF BETA INTERFERON IN MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCOLOSIS ANTIBODIES RESPONSE IN MS SARDINIAN PATIENTS J. FRAU, D. COSSU, G. COGHE, L. LOREFICE, G. FENU, M. MELIS, G. PORCU, M. MURRU, S. TRANQUILLI, M. MARROSU, L. SECHI, E. COCCO (Cagliari, Sassari) 502. IS FINGOLIMOD DISCONTINUATION NECESSARY AFTER ASYMPTOMATIC LYMPHOCYTOPENIA A CASE REPORT V. PRONE, R. MARAZZI, L. LA MANTIA, C. ERMINIO, L. DE TONI FRANCESCHINI, F. IMBESI, E. AGOSTONI, A. PROTTI (Milano) 503. FAMPRIDINE IS EFFECTIVE ON WALKING ABILITY IN A SUBGROUP OF MULTIPLE SCLEROSIS PATIENTS C. SOLARO, E. TRABUCCO, M. CELLA, P. TANGANELLI (Genova) 504. ORAL FAMPRIDINE IMPROVES STANDING BALANCE DETECTED AT STATIC POSTUROGRAPHY IN MULTIPLE SCLEROSIS L. PROSPERINI, C. GIANNÌ, D. FORTUNA, M. MARCHETTI, C. POZZILLI (Roma) 505. A TOLL-FREE HELPLINE DEDICATED TO MULTIPLE SCLEROSIS: PATIENTS’ SATISFACTION AND IMPACT ON HEALTHCARE PROVIDERS L. PROSPERINI, V. BIANCHI, I. LUZI, G. BORRIELLO, C. POZZILLI (Roma) 506. GAIT INITIATION EVALUATION IN MULTIPLE SCLEROSIS G. COGHE, M. GALLI, M. PAU, J. FRAU, L. LOREFICE, G. FENU, M. MELIS, M. MARROSU, E. COCCO (Cagliari, Milano) 507. PATHOPHYSIOLOGY OF TISSUE DAMAGE IN PROGRESSIVE MULTIPLE SCLEROSIS: AN IMMUNOLOGICAL AND MRI COMPARATIVE STUDY VERSUS MOTOR NEURON DISEASE P. TORTORELLA, M. LAGANÀ, M. SARESELLA, L. GRIFFANTI, E. TAVAZZI, I. MARVENTANO, G. PINARDI, M. CORBO, C. LUNETTA, P. CECCONI, D. CAPUTO, M. CLERICI, M. ROVARIS (Milano) 170
508. FACTORS INFLUENCING RECOVERY AFTER MULTIPLE SCLEROSIS RELAPSES: A POSSIBLE ROLE OF URIC ACID S. MASERA, F. VALLELONGA, L. MARINO, A. MATTIODA, G. SUPERTI, A. ROMAGNOLO, E. BINELLO, M. VERCELLINO, C. CHIAVAZZA, L. PINESSI, P. CAVALLA (Torino) 509. INCREASE IN INTENSITY AND FREQUENCY OF COMORBID MIGRAINE IN FINGOLIMOD-TREATED MULTIPLE SCLEROSIS PATIENTS E. BINELLO, S. MASERA, A. MATTIODA, G. SUPERTI, A. ROMAGNOLO, F. VALLELONGA, L. MARINO, P. CAVALLA, L. PINESSI (Torino) 510. ASPECTS OF PHARMACOECONOMY IN MULTIPLE SCLEROSIS: ADHERENCE TO IMMUNOMODULATORY THERAPIES AS AN INDEX OF THE DIRECT COST OF ILLNESS. EXPERIENCE OF THE FIDENZA- PARMA’S CENTRE I. PESCI, C. DE BONA, A. GUARESCHI, G. PEDÀ, E. MONTANARI (Fidenza - PR, Parma) 511. NATALIZUMAB OR FINGOLIMOD FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS: A PROSPECTIVE STUDY A. GAJOFATTO, M. BIANCHI, M. BENEDETTI (Verona) 512. REFRACTORY TRIGEMINAL NEURALGIA SUCCESSFULLY TREATED BY COMBINATION THERAPY (PREGABALIN AND LAMOTRIGINE) E. TRABUCCO, M. CELLA, P. TANGANELLI, C. SOLARO (Genova) 513. IS MULTIPLE SCLEROSIS A RESULT OF EXCESSIVE INNATE IMMUNE RESPONSE T. KOUDRIAVTSEVA, G. D’AGOSTO, C. MANDOJ, P. CORDIALI-FEI (Roma) 514. NEW MARKER FOR PATIENTS WITH MULTIPLE SCLEROSIS: A TRANSCRANIAL BRAIN PHOTOPLETHYSMOGRAPHY STUDY S. VIOLA, P. VIOLA, M. BUONGARZONE, L. FIORELLI, P. LITTERIO (Vasto - CH, Atessa - CH) 515. THE COMBINATION OF IFNBETA 1A S.C. WITH ORAL CONTRACEPTIVES AT HIGH DOSE ESTROGENS IMPROVES COGNITIVE IMPAIRMENT OF WOMEN WITH MULTIPLE SCLEROSIS L. DE GIGLIO, F. DE ANGELIS, F. MARINELLI, V. BARLETTA, P. PANTANO, V. TOMASSINI, C. POZZILLI (Roma, Cardiff - UK) 516. PROLACTIN LEVEL CAN AFFECT BRAIN DAMAGE IN MULTIPLE SCLEROSIS L. DE GIGLIO, F. MARINELLI, V. BARLETTA, F. DE ANGELIS, L. PROSPERINI, V. TOMASSINI, C. POZZILLI (Roma, Cardiff - UK) 517. FINGOLIMOD FIRST DOSE SAFETY IN CLINICAL PRACTICE F. SACCÀ, G. PUORRO, A. MARSILI, C. PANE, R. LANZILLO, S. SABATINI, V. BRESCIA MORRA (Napoli, Origgio - VA) 518. EFFICACY OF FINGOLIMOD IN MULTIPLE SCLEROSIS AND BLOOD LYMPHOCYTES COUNT: A POSSIBLE CORRELATION D. BARONCINI, M. ZAFFARONI, A. GHEZZI, A. BIANCHI, P. ANNOVAZZI, S. BALDINI, G. MINONZIO, G. COMI (Milano, Gallarate - VA) 519. DISCONTINUATION OF TREATMENT WITH NATALIZUMAB AFTER 24 COURSES. REPORT FROM A SPONTANEOUS, OBSERVATIONAL, PROSPECTIVE STUDY (TYSTOP) M. CLERICO, S. DE MERCANTI, F. PIAZZA, E. VERSINO, D. GNED, M. GIBBIN, V. BRESCIA MORRA, R. LANZILLO, L. AMATO, M. QUARANTELLI, A. GHEZZI, A. BIANCHI, D. BARONCINI, G. SALEMI, S. REALMUTO, M. FERRÒ, F. VITETTA, M. D’ONGHIA, D. PAOLICELLI, M. TROJANO, L. DURELLI (Orbassano - TO, Napoli, Gallarate - VA, Palermo, Crema - CR, Modena, Bari) 520. CYP7B1 SCREENING IN MULTIPLE SCLEROSIS: POSSIBLE ROLE OF OXYSTEROL METABOLISM S. PELUSO, C. CRISCUOLO, R. CARBONE, M. LIETO, A. FILLA, R. LANZILLO, M. QUARANTELLI, V. BRESCIA MORRA, G. DE MICHELE (Napoli) 4 N O V E M B R E • A R E A P O S T E R 171
Page 1:
2 5
Page 7 and 8:
Sotto l’Alto Patronato della Pres
Page 9 and 10:
CONSIGLIO DIRETTIVO SIN Presidente
Page 11 and 12:
IN TRENO Stazione Centrale - Stazio
Page 13:
Accademia Nazionale di Medicina 16
Page 16 and 17:
AUDITORIUM SALA SILVER 12.30 - 13.3
Page 18 and 19:
2 N O V E M B R E • S A L A G I A
Page 20 and 21:
2 N O V E M B R E • S A L A CORSO
Page 22 and 23:
Page 24 and 25:
2 N O V E M B R E • CORSO A.N.I.N
Page 26 and 27:
2 N O V E M B R E • S A L A SIMPO
Page 28 and 29:
2 N O V E M B R E • S A L A B L U
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
DOMENICA 3 NOVEMBRE AUDITORIUM SALA
Page 36 and 37:
3 N O V E M B R E • A U D I T O R
Page 38 and 39:
Page 40 and 41:
3 N O V E M B R E • S A L A R O S
Page 42 and 43:
3 N O V E M B R E • COMUNICAZIONI
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
3 N O V E M B R E • S A L A B I A
Page 50 and 51:
3 N O V E M B R E • S A L A RIUNI
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
3 N O V E M B R E • S A L A WORKS
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
LUNEDI 4 NOVEMBRE AUDITORIUM SALA S
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
4 N O V E M B R E • COMUNICAZIONI
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
4 N O V E M B R E • LETTURA ore 1
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
MARTEDI 5 NOVEMBRE AUDITORIUM SALA
Page 102 and 103:
5 N O V E M B R E • S A L A BREAK
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
5 N O V E M B R E • S A L A T U R
Page 116 and 117:
5 N O V E M B R E • S A L A TRIAL
Page 118 and 119:
Page 120 and 121:
Page 122 and 123: 5 N O V E M B R E • S A L A G I A
Page 124 and 125: 5 N O V E M B R E • S A L A B I A
Page 126 and 127: 5 N O V E M B R E • CHIUSURA DEI
Page 128 and 129: 3 N O V E M B R E • A R E A P O S
Page 152 and 153: 150
Page 194 and 195: 5 N O V E M B R E • A R E A 754.
Page 200 and 201: SEGRETERIA IN SEDE CONGRESSUALE La
Page 202 and 203: ACCREDITAMENTO ECM La Commissione N
Page 204 and 205: CERTIFICATO ECM Fin quando non era
Page 207 and 208: Si ringraziano, per l’indispensab
Page 209 and 210: SI RINGRAZIANO PER LA PARTECIPAZION
Page 212: SEGRETERIA ORGANIZZATIVA SIN Studio
show all

programma definitivo - SocietÃ italiana di neurologia

Create successful ePaper yourself

Delete template?

Save as template?